Skip to main content
. 2016 Aug 30;87(9):897–904. doi: 10.1212/WNL.0000000000003044

Figure 3. [11C]-Flumazenil PET binding differences between patients with NF1 and controls.

Figure 3

Areas showing decreased [11C]-flumazenil binding in patients (contrast control > NF1, p < 0.05 corrected). NF1 = neurofibromatosis type 1.